Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EXELIXIS, INC.EXEL · Entity 3386 | Director | May 26, 2022 | May 28, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EXELIXIS, INC.
Report date May 26, 2022 · Filed May 28, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 93,989 |
Reported balance
After 2022-05-26 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-05-26 · Grant · Acquired 19,575 · Balance 93,989 F1: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 100% of the shares subject to the restricted stock unit award on May 26, 2023, subject to the Reporting Person's continuous service through that date. F3: Includes 19,575 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock.
F2: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 100% of the shares subject to the restricted stock unit award on May 26, 2023, subject to the Reporting Person's continuous service through that date.
F3: Includes 19,575 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 26, 2022 Filed May 28, 2022 01:13 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 19,575 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-22-000078 · wf-form4_165370041624609.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,989 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 100% of the shares subject to the restricted stock unit award on May 26, 2023, subject to the Reporting Person's continuous service through that date. F3 · balance_after: Includes 19,575 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 27, 2021 Filed May 29, 2021 00:28 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 16,598 | $0.00 Strike: $22.48 | $0.00 |
DisclosureSEC source: 0000939767-21-000064 · wf-form4_162224807212123.xml · derivative · entry 2 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,598 Underlying: Common Stock · 16,598 shares Expires 2028-05-26 F4 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date. Read SEC document |
| May 27, 2021 Filed May 29, 2021 00:28 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 8,299 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000064 · wf-form4_162224807212123.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,414 F1 · security: Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 100% of the shares subject to the restricted stock unit award on May 27, 2022, subject to the Reporting Person's continuous service through that date. F3 · balance_after: Includes 8,299 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 14, 2021 Filed May 18, 2021 00:13 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 40,000 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0000939767-21-000053 · wf-form4_162129678672791.xml · derivative · entry 3 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2023-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 26, 2016. Read SEC document |
| May 14, 2021 Filed May 18, 2021 00:13 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 40,000 | $25.04 | $1,001,600.00 |
DisclosureSEC source: 0000939767-21-000053 · wf-form4_162129678672791.xml · nonDerivative · entry 2 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,115 Read SEC document |
| May 14, 2021 Filed May 18, 2021 00:13 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 40,000 | $6.30 | $252,000.00 |
DisclosureSEC source: 0000939767-21-000053 · wf-form4_162129678672791.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 7,728 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 01:15 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 24,097 | $22.29 | $537,122.13 |
DisclosureSEC source: 0000939767-21-000024 · wf-form4_161421570407092.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,115 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.27 to $22.30. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. F2 · balance_after: Includes 7,728 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| November 24, 2020 Filed Nov 26, 2020 00:46 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 40,004 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0000939767-20-000158 · wf-form4_160635156809212.xml · derivative · entry 3 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,004 shares Expires 2020-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 80,004 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2013. Read SEC document |
| November 24, 2020 Filed Nov 26, 2020 00:46 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 40,004 | $18.50 | $740,074.00 |
DisclosureSEC source: 0000939767-20-000158 · wf-form4_160635156809212.xml · nonDerivative · entry 2 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,212 Read SEC document |
| November 24, 2020 Filed Nov 26, 2020 00:46 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 40,004 | $5.82 | $232,823.28 |
DisclosureSEC source: 0000939767-20-000158 · wf-form4_160635156809212.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 7,728 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 21, 2020 Filed May 23, 2020 01:11 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 40,000 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0000939767-20-000100 · wf-form4_159019623618786.xml · derivative · entry 5 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,004 Underlying: Common Stock · 40,000 shares Expires 2020-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 80,004 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2013. Read SEC document |
| May 21, 2020 Filed May 23, 2020 01:11 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 15,456 | $0.00 Strike: $24.62 | $0.00 |
DisclosureSEC source: 0000939767-20-000100 · wf-form4_159019623618786.xml · derivative · entry 4 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,456 Underlying: Common Stock · 15,456 shares Expires 2027-05-20 F5 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date. Read SEC document |
| May 21, 2020 Filed May 23, 2020 01:11 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 40,000 | $24.64 | $985,600.00 |
DisclosureSEC source: 0000939767-20-000100 · wf-form4_159019623618786.xml · nonDerivative · entry 3 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,212 F4 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.56 to $25.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4. Read SEC document |
| May 21, 2020 Filed May 23, 2020 01:11 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 40,000 | $5.82 | $232,800.00 |
DisclosureSEC source: 0000939767-20-000100 · wf-form4_159019623618786.xml · nonDerivative · entry 2 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,212 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2020 Filed May 23, 2020 01:11 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 7,728 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000100 · wf-form4_159019623618786.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,212 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 100% of the shares subject to the restricted stock unit award on May 21, 2021, subject to the Reporting Person's continuous service through that date. F3 · balance_after: Includes 18,045 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 11, 2020 Filed May 14, 2020 01:16 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 30,000 | $0.00 Strike: $4.58 | $0.00 |
DisclosureSEC source: 0000939767-20-000080 · wf-form4_158941895308188.xml · derivative · entry 3 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 30,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 23, 2013. Read SEC document |
| May 11, 2020 Filed May 14, 2020 01:16 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 30,000 | $26.30 | $789,000.00 |
DisclosureSEC source: 0000939767-20-000080 · wf-form4_158941895308188.xml · nonDerivative · entry 2 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,484 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.00 to $26.70. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| May 11, 2020 Filed May 14, 2020 01:16 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 30,000 | $4.58 | $137,400.00 |
DisclosureSEC source: 0000939767-20-000080 · wf-form4_158941895308188.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 10,317 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| January 15, 2020 Filed Jan 18, 2020 01:50 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 61,683 | $20.01 | $1,234,276.83 |
DisclosureSEC source: 0000939767-20-000010 · wf-form4_157931221340472.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,484 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2019. F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.01. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. F3 · balance_after: Includes 10,317 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 23, 2019 Filed May 25, 2019 00:35 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 20,634 | $0.00 Strike: $19.77 | $0.00 |
DisclosureSEC source: 0000939767-19-000131 · wf-form4_155874452985856.xml · derivative · entry 2 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,634 Underlying: Common Stock · 20,634 shares Expires 2026-05-22 F4 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date. Read SEC document |
| May 23, 2019 Filed May 25, 2019 00:35 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 10,317 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-19-000131 · wf-form4_155874452985856.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,167 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 100% of the shares subject to the restricted stock unit award on May 23, 2020, subject to the Reporting Person's continuous service through that date. F3 · balance_after: Includes 10,317 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 00:32 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $4.57 | $0.00 |
DisclosureSEC source: 0000939767-19-000046 · wf-form4_155088191775816.xml · derivative · entry 7 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2019-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 24, 2012. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 00:32 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $5.92 | $0.00 |
DisclosureSEC source: 0000939767-19-000046 · wf-form4_155088191775816.xml · derivative · entry 6 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2020-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2010. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 00:32 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 11,250 | $0.00 Strike: $4.16 | $0.00 |
DisclosureSEC source: 0000939767-19-000046 · wf-form4_155088191775816.xml · derivative · entry 5 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,250 shares Expires 2019-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 11,250 shares of Exelixis, Inc. common stock, became fully exercisable on May 14, 2009. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 00:32 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 41,250 | $21.50 | $886,875.00 |
DisclosureSEC source: 0000939767-19-000046 · wf-form4_155088191775816.xml · nonDerivative · entry 4 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,850 Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 00:32 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 15,000 | $4.57 | $68,550.00 |
DisclosureSEC source: 0000939767-19-000046 · wf-form4_155088191775816.xml · nonDerivative · entry 3 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 00:32 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 15,000 | $5.92 | $88,800.00 |
DisclosureSEC source: 0000939767-19-000046 · wf-form4_155088191775816.xml · nonDerivative · entry 2 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 00:32 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 11,250 | $4.16 | $46,800.00 |
DisclosureSEC source: 0000939767-19-000046 · wf-form4_155088191775816.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 7,937 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 23:39 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 40,000 | $0.00 Strike: $3.38 | $0.00 |
DisclosureSEC source: 0000939767-18-000184 · wf-form4_153454913151692.xml · derivative · entry 3 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2021-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 29, 2014. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 23:39 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 40,000 | $19.50 | $780,000.00 |
DisclosureSEC source: 0000939767-18-000184 · wf-form4_153454913151692.xml · nonDerivative · entry 2 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,850 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.50 to $19.52. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 23:39 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 40,000 | $3.38 | $135,200.00 |
DisclosureSEC source: 0000939767-18-000184 · wf-form4_153454913151692.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 7,937 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 24, 2018 Filed May 25, 2018 00:26 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 15,874 | $0.00 Strike: $20.50 | $0.00 |
DisclosureSEC source: 0000939767-18-000107 · wf-form4_152720794202244.xml · derivative · entry 2 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,874 Underlying: Common Stock · 15,874 shares Expires 2025-05-23 F4 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/12th of the shares subject to the option each month following the date of grant, subject to the Reporting Person's continuous service through such dates. Read SEC document |
| May 24, 2018 Filed May 25, 2018 00:26 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 7,937 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-18-000107 · wf-form4_152720794202244.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,850 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 100% of the shares subject to the restricted stock unit award on May 24, 2019, subject to the Reporting Person's continuous service through such date. F3 · balance_after: Includes 13,780 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 11, 2018 Filed May 11, 2018 23:58 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $11.66 | $0.00 |
DisclosureSEC source: 0000939767-18-000081 · wf-form4_152608304741745.xml · derivative · entry 3 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2011. Read SEC document |
| May 11, 2018 Filed May 11, 2018 23:58 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 15,000 | $19.03 | $285,450.00 |
DisclosureSEC source: 0000939767-18-000081 · wf-form4_152608304741745.xml · nonDerivative · entry 2 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,913 F2 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2018. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $18.85 to $19.32. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| May 11, 2018 Filed May 11, 2018 23:58 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 15,000 | $11.66 | $174,900.00 |
DisclosureSEC source: 0000939767-18-000081 · wf-form4_152608304741745.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 5,843 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 00:23 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $7.97 | $0.00 |
DisclosureSEC source: 0000939767-18-000038 · wf-form4_152046862084063.xml · derivative · entry 3 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2008. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 00:23 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 15,000 | $24.73 | $370,950.00 |
DisclosureSEC source: 0000939767-18-000038 · wf-form4_152046862084063.xml · nonDerivative · entry 2 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,913 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.53 to $25.00. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 00:23 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 15,000 | $7.97 | $119,550.00 |
DisclosureSEC source: 0000939767-18-000038 · wf-form4_152046862084063.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 5,843 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 25, 2017 Filed May 27, 2017 00:48 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 11,686 | $0.00 Strike: $19.57 | $0.00 |
DisclosureSEC source: 0000939767-17-000111 · wf-form4_149584610002009.xml · derivative · entry 2 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,686 Underlying: Common Stock · 11,686 shares Expires 2024-05-24 F4 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/12th of the shares subject to the option each month following the date of grant, subject to the Reporting Person's continuous service through such dates. Read SEC document |
| May 25, 2017 Filed May 27, 2017 00:48 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 5,843 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-17-000111 · wf-form4_149584610002009.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,913 F1 · security: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 100% of the sharessubject to the restricted stock unit award on May 25, 2018, subject to the Reporting Person's continuous service through such date. F3 · balance_after: Includes 5.843 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 00:00 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.53 | $0.00 |
DisclosureSEC source: 0000939767-17-000053 · wf-form4_149135043435843.xml · derivative · entry 3 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2017-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 10,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2007. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 00:00 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 10,000 | $21.30 | $213,000.00 |
DisclosureSEC source: 0000939767-17-000053 · wf-form4_149135043435843.xml · nonDerivative · entry 2 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,070 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 22, 2016. F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.07 to $21.64. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 00:00 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 10,000 | $10.53 | $105,300.00 |
DisclosureSEC source: 0000939767-17-000053 · wf-form4_149135043435843.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2017 Filed Mar 11, 2017 00:37 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 40,000 | $0.00 Strike: $3.13 | $0.00 |
DisclosureSEC source: 0000939767-17-000033 · wf-form4_148919262208619.xml · derivative · entry 3 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2022-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 28, 2015. Read SEC document |
| March 10, 2017 Filed Mar 11, 2017 00:37 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 40,000 | $21.98 | $879,200.00 |
DisclosureSEC source: 0000939767-17-000033 · wf-form4_148919262208619.xml · nonDerivative · entry 2 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,070 Read SEC document |
| March 10, 2017 Filed Mar 11, 2017 00:37 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 40,000 | $3.13 | $125,200.00 |
DisclosureSEC source: 0000939767-17-000033 · wf-form4_148919262208619.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.